Monograph
J01CF02 - Cloxacillin |
Not porphyrinogenic |
NP |
Rationale
Metabolised only to a limited extent. Two references state non-porphyrinogenicity.
Chemical description
Penicillinase stable penicillin used parenterally (up to 2 g x 3) in staphylococcal infections mainly eliminated in unchanged form by renal ecxretion. No clear data pointing to CYP-interaction. Half life in blood is 30 minutes, 30-50 % of the dose being excreted within 6 hours. South African list: use. Australian list: safe.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Denmark
Cloxacillin · Cloxacillin "Macure" · Cloxacillin "Navamedic" · Cloxacillin "Stragen" · Cloxacillin "Vital Pharma Nordic"Norway
Cloxacillin Navamedic · Cloxacillin Stragen · Cloxacillin VM navamedic SA · Teva-CloxacillinPoland
SyntarpenIceland
Cloxacillin · Cloxacillin Navamedic · Cloxacillin Vital Pharma NordicFinland
Cloxacillin · Cloxacillin Vital Pharma Nordic · Cloxacillin Macure · Cloxacillin Navamedic · Cloxacillin Stragen · Cloxacillin XGX Pharma
© NAPOS 2024